微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 14.27% | 4.05% | -3.86% | 47/52 | 36.36% | 百奥赛图 | 74.91% | 行业排名> |
| 2025-06-30 | 14.85% | 10.09% | -1.6% | 48/52 | 36.49% | 百奥赛图 | 74.39% | 行业排名> |
| 2025-03-31 | 15.09% | 9.61% | 12.69% | 46/52 | 34.34% | *ST生物 | 64.96% | 行业排名> |
| 2024-12-31 | 13.39% | -0.73% | -2.41% | 46/52 | 35.25% | 百奥赛图 | 77.67% | 行业排名> |
| 2024-09-30 | 13.72% | -1.52% | 1.72% | 46/52 | 35.76% | *ST生物 | 68.03% | 行业排名> |
| 2024-06-30 | 13.48% | -6.2% | -2.02% | 47/52 | 36.65% | 百奥赛图 | 74.42% | 行业排名> |
| 2024-03-31 | 13.76% | 5.34% | 2.06% | 45/52 | 35.74% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 13.49% | -3.26% | -3.18% | 47/52 | 38.77% | 百奥赛图 | 70.59% | 行业排名> |
| 2023-09-30 | 13.93% | 10.76% | -3.12% | 46/52 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 14.38% | 15.14% | 10.04% | 47/52 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 13.07% | 40.88% | -6.27% | 46/52 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 13.94% | 85.44% | 10.85% | 49/52 | 40.75% | 百奥赛图 | 73.38% | 行业排名> |
| 2022-09-30 | 12.58% | 74.12% | 0.71% | 43/52 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 12.49% | 45.89% | 34.64% | 47/52 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 9.27% | -19.7% | 23.37% | 41/52 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 7.52% | 1399.84% | 4.08% | 49/52 | 42.48% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 7.22% | 180.39% | -15.62% | 38/52 | 43.07% | *ST生物 | 84.53% | 行业排名> |
| 2021-06-30 | 8.56% | 173.38% | -25.89% | 46/52 | 42.6% | *ST生物 | 83.19% | 行业排名> |
| 2021-03-31 | 11.55% | 2086.69% | 2204.19% | 31/52 | 39.47% | *ST生物 | 83.9% | 行业排名> |
| 2020-12-31 | 0.5% | -92.51% | -80.54% | 48/52 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 2.58% | -63.01% | -17.73% | 32/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 3.13% | -62.22% | 638.59% | 38/52 | 39.28% | *ST生物 | 78.74% | 行业排名> |
| 2020-03-31 | -0.58% | -107.44% | -108.69% | 29/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 6.69% | -18.28% | -3.96% | 49/52 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 6.96% | -12.47% | -15.98% | 30/52 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 8.29% | 12.55% | 6.1% | 33/52 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 7.81% | -7.33% | -4.54% | 29/52 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 8.18% | -25.38% | 2.86% | 47/52 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 7.96% | -34.89% | 8.04% | 28/52 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 7.36% | -37.6% | -12.64% | 33/52 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 8.43% | -31.61% | -23.14% | 27/52 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 10.97% | -16.18% | -10.24% | 42/52 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 12.22% | -13% | 3.53% | 26/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 11.8% | -7.58% | -4.25% | 30/52 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 12.33% | 12.88% | -5.79% | 23/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 13.08% | -5.01% | -6.84% | 31/52 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 14.04% | 9.48% | 9.98% | 20/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 12.77% | 6.56% | 16.95% | 21/52 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 10.92% | 12.59% | -20.73% | 16/52 | 28.42% | 盈康生命 | 75.69% | 行业排名> |